The Virology Laboratory Core provides the HSV virus culture service, directed by Drs. Corey and Ashley, includes virus isolation and antigen detection to identify infectious HSV in genital lesions and in oral, genital and rectal secretions (Projects I, III, IV). All women delivering infants at the two participating hospitals are sampled at delivery for virus isolation provided by the Laboratory Core (Project II). The Core will also provide antiviral sensitivity testing on subsets of isolates from Projects I and III. HSV type specific Western blot service, directed by Dr. Ashley, is provided for on prenatal and delivery serum pairs to identify women seroconverting to HSV during pregnancy (Project II). This test is also provided in support of Projects I, III, and IV to determine serostatus for subject cohorting as: seronegative for HSV, HSV-1 seropositive, HSV-2 seropositive or seropositive for both HSV- 1 and HSV-2. These services will be centralized in a single location at CHMC along with the isolate and serum banks and their respective computer databases which interface with the facilities of the Project Database Manager. In addition, HSV PCR services, directed by Dr. Cone, include diagnosis of low titer viral shedding by detection of amplified HSV DNA, determination of actively replicating HSV by detection of amplified HSV RNA, quantitative RNA and quantitative DNA to provide measures of viral load at sites of HSV shedding. In selected cases, restriction enzyme and sequence analyses will be performed in conjunction with the HSV-PCR service. In addition to laboratory service work relating to HSV diagnosis, an HIV service component, directed by Drs. Corey and Coombs, is included in the Laboratory Core in support of Project III. The tests provided are all certified by the AIDS Collaborative Treatment Group and/or the College of American Pathologists and include: HIV antibody binding and neutralizing assays in cell lines and in PBMCs, p24 antigen determinations, measurement of mucosal antibodies by chemiluminescence immunoblot, HIV isolation, and quantitation, determination of fusogenic characteristics of isolates, antiviral sensitivity testing of isolates, detection and quantitation of HIV RNA by PCR and branched chain PCR and detection and quantitation of DNA, and DNA replicative intermediates by PCR. All methods described in the Virology Laboratory Core have exhaustive integral quality control measures and are used routinely in the laboratories of the faculty who will direct the respective support services for the Program Project.

Project Start
1997-04-01
Project End
1998-09-14
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
7
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Seattle Children's Hospital
Department
Type
DUNS #
048682157
City
Seattle
State
WA
Country
United States
Zip Code
98105
Schiffer, Joshua T; Swan, Dave A; Roychoudhury, Pavitra et al. (2018) A Fixed Spatial Structure of CD8+ T Cells in Tissue during Chronic HSV-2 Infection. J Immunol 201:1522-1535
Traidl, Stephan; Kienlin, Petra; Begemann, Gabriele et al. (2018) Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus-specific type 2 immune responses. J Allergy Clin Immunol 141:1144-1147.e5
Ramchandani, Meena; Selke, Stacy; Magaret, Amalia et al. (2018) Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition. Sex Transm Infect 94:568-570
Boucoiran, Isabelle; Mayer, Bryan T; Krantz, Elizabeth M et al. (2018) Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants. Pediatr Infect Dis J 37:627-631
Kleinstein, Sarah E; Shea, Patrick R; Allen, Andrew S et al. (2018) Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2). Genes Immun :
Gottlieb, Sami L; Giersing, Birgitte; Boily, Marie-Claude et al. (2017) Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling. Vaccine :
Mayer, Bryan T; Krantz, Elizabeth M; Swan, David et al. (2017) Transient Oral Human Cytomegalovirus Infections Indicate Inefficient Viral Spread from Very Few Initially Infected Cells. J Virol 91:
Posavad, C M; Zhao, L; Dong, L et al. (2017) Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract. Mucosal Immunol 10:1259-1269
Johnston, Christine; Magaret, Amalia; Roychoudhury, Pavitra et al. (2017) Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study. PLoS Med 14:e1002475
Matrajt, Laura; Gantt, Soren; Mayer, Bryan T et al. (2017) Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children. Sci Rep 7:13105

Showing the most recent 10 out of 345 publications